The IRCM Foundation reaffirms its role as a strategic partner of the Institute: thanks to the support of its donors and partners, the Foundation contributed $4,518,471 to the IRCM at the end of the 2025-2026 fiscal year.
This contribution directly supports:
- Research efforts aimed at better understanding diseases and developing new diagnostic, preventative, and therapeutic approaches ($3,507,128);
- The training of the next generation of scientists, including students and interns who represent the future of research ($476,000);
- The upgrading of research infrastructure and equipment to provide teams with the resources necessary to conduct cutting-edge work ($535,343).
These investments help foster an environment where innovation can take root and where teams are empowered to tackle major health challenges.
This allocation of funds reflects a clear commitment: to support the advancement of knowledge about diseases, train the scientists of tomorrow, and maintain cutting-edge research platforms and laboratories.
“Each donation represents much more than financial support: it is an investment in knowledge, innovation, and the training of tomorrow’s scientists. Thanks to the trust of our donors and partners, the Foundation helps provide the IRCM teams with the resources to pursue research that can transform the lives of many people,” emphasizes Martin Bourassa, Chair of the IRCM Foundation’s Board of Directors.
“The Foundation’s contribution is essential to cultivating a high-performing and attractive research environment conducive to innovative research. This funding allows us to support promising projects, train the next generation of scientists, and provide our teams with world-class infrastructure, three essential elements for advancing our mission,” emphasizes Dr. Jean-François Côté, President and Scientific Director of the IRCM.
This contribution is a valuable boost, enabling the IRCM to work on developing the therapies of tomorrow and training the researchers who will shape the medicine of the future.
